Novartis Lifts Annual Revenue and Earnings Outlook Amid Strong Drug Portfolio SREA Q1 2026 Earnings Slight EPS Miss as Stock Rises 045 Novartis Raises FullYear Sales and Profit Guidance Signaling Strong Operational Momentum